| Trading Companies & Distributors Industry | Industrials Sector | Colonel Timothy D. Ringgold CEO | OTC PINK Exchange | 81946R107 CUSIP |
| US Country | 3 Employees | - Last Dividend | 25 Sep 2017 Last Split | - IPO Date |
Shanrong Biotechnology Corp. is a versatile enterprise that has expanded its operational horizons from project management and executive consulting to a more niche domain of refurbishing and enhancing armored vehicles, primarily for military and police applications. Initially established under the name Defense Solutions Holding, Inc., the company underwent a rebranding to Shanrong Biotechnology Corp. in September 2017. This strategic shift reflects a broader vision of the company, not just in the defense sector but also marking a potential pivot or broadening towards biotechnology. Based in Beverly Hills, California, Shanrong Biotechnology Corp. showcases a repertoire that spans across a variety of sectors including defense, homeland security, information technology, and telecommunications, indicating a diverse yet focused operational approach.